Home -> Law Blog Directory -> Patent Law Blogs -> IPBiz
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: IPBizKyl patent reform bill: only for show
By Lawrence B. Ebert, Esq.
Section 5 concerns POST-GRANT REVIEW PROCEEDINGS, and basically substitutes "oppositions" (with two windows) for inter partes re-examinations.
Note-->
??(a) IN GENERAL.?The presumption of validity set
forth in section 282 of this title shall apply in post-grant
review proceedings instituted under this chapter.
??(b) BURDEN OF PROOF.?The petitioner shall have
the burden of proving a proposition of invalidity by a pre-
ponderance of the evidence in a first-period proceeding
and by clear and convincing evidence in a second-period
proceeding.
Section 7 is titled SUBMISSIONS BY THIRD PARTIES AND OTHER QUALITY ENHANCEMENTS. It notes: Any person may submit for
consideration and inclusion in the record of a patent application, any patent, published patent application,
or other publication of potential relevance to the examination of the application, if such submission is
made in writing before the earlier of (...)
One notes that Rule 99 already allows third parties to submit prior art to the USPTO.
Section 8 pertains to venue, and limits venue to places meeting one of six conditions. Condition 4 is where the invention claimed in a patent in suit was conceived or actually reduced to practice.
Section 13 concerns patents on check imaging methods.
Section 14 deals with USPTO funding, and would create a USPTO Public Enterprise Fund, the funds of which are available to the Director without fiscal year limitation.
Full post as published by IPBiz on September 26, 2008 (boomark / email).
Transportation Equity Act for the 21st Century
TEA-21 - Plus Law 105-178
Federal Transportation Equity Act of 2005
Safe, Accountable, Flexible, Efficient Transportation Equity Act: A Legacy for Users
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Texas, USA
alleging the Medical Malpractice and Tort Reform Act of 2003 violates several provisions of the Constitution.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
Phone Bill Reduction
Qwest agrees to $16 million settlement in overcharging lawsuit.
Lipitor
Review of Studies Show No Significant Benefit in Women
Tarceva
Safety Data Show Association with Liver Failure and Death

Compromise on patent reform bill, or mere delusion
Senate Patent Reform Bill: R.I.P.
Senate Patent Reform Legislation -- One Old Bill and One New Bill
Eyewitness reform bill fails; DNA on arrest bill passes
IPO Urges Action Against Patent Reform Bill Provision








